期刊文献+

炎性因子的基因多态性在阿尔茨海默病中的研究进展 被引量:1

Recent advance in gene polymorphisms of inflammatory cytokines in Alzheimer's disease
原文传递
导出
摘要 中枢神经系统炎症反应在AD发病过程中发挥重要作用,促炎因子可引起机体炎症反应,增强β淀粉样蛋白(AB)引起的神经毒性作用,促进AD发病;抗炎因子则能够下调炎症反应,发挥保护作用并促使受损组织重建。然而,基因多态性的存在使得炎性因子对AD发病的影响错综复杂,在不同种群中存在很大的差异,研究并阐明炎性因子基因多态性与AD发病的关系有助于AD发病机制的研究,并为AD的治疗提供新的线索。故本文围绕上述内容综述如下。 The central nervous system inflammatory response plays an important role in the pathogenesis of AD. Pro-inflammatory cytokines can induce inflammatory reactions in the body, enhance the neurotoxic effects caused by Aβ, promote the pathogenesis of AD and anti-inflammatory factors can down-regulate the inflammatory response, play a protective role and promote the reconstruction of damaged tissue. However, due to the existence of genetic polymorphisms, the influence of inflammatory factors on AD is complicated, especially in different population groups. Studing and clarifying the relationship between gene polymorphisms of inflammatory factors and and the pathogenesis of AD will promote the study of the mechanism of AD and provide a new method for the treatment of AD. Therefore, this article mainly reviews this.
作者 李倩倩 李兰珺 丁单华 张爽 吴军 Li Qianqian;Li Lanjun;Ding Danhua;Zhang Shuang;Wu Jun(Department of Neurology, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, Chin)
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2018年第6期640-644,共5页 Chinese Journal of Neuromedicine
基金 国家自然科学基金(U1604181) 河南省基础与前沿技术研究计划项目(142300410390)
关键词 阿尔茨海默病 炎性因子 基因多态性 Alzheimer's disease Inflammatory cytokines Gene polymorphisms
  • 相关文献

参考文献4

二级参考文献58

  • 1Felderhoff-Mueser U, Schmidt OI, Oberholzer A, et al. IL-18: a key player in neuroinflammation and neurodegeneration? [J]. Trends Nenrosci, 2005, 28(9): 487-493.
  • 2Ojala J, Alafuzoff I, Herukka SK, et al. Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients[J]. Neurobiol Aging, 2009, 30(2): 198-209.
  • 3Malaguarnera L, Motta M, Rosa MD, et al. Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer's disease and vascular dementia[J]. Neuropathology, 2006, 26(4): 307-312.
  • 4Motta M, Imbesi MR, Rosa D, et al. Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression[J]. Immunol Lett, 2007, 114(1): 46-51.
  • 5Yu JT, Tan L, Song JH, et al. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease [J]. Brain Res, 2009, 1253: 169-175.
  • 6Eikelenboom P, Veerhuis R, Scheper W, et al. The significance of neuroinflammation in understanding Alzheimer's disease [J]. Neural Transm, 2006, 113(11): 1685-1695.
  • 7Bossu P, Ciaramella A, Salani F, et al. Interleukin-18 produced by peripheral blood cells is increased in Alzheimer's disease and correlates with cognitive impairment [J]. Brain Behav Immun, 2008, 22(4): 487-492.
  • 8Ojala J, Alafuzoff I, Herttkka SK, et al. Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients [J]. Neurobiol Aging, 2009, 30(2): 198-209.
  • 9Segat L, Milanese M, Arosio B, et al. Lack of association between Interleukin-18 gene promoter polymorphisms and onset of Alzheimer's disease[J]. Neurobiol Aging, 2010, 31(1): 162-164.
  • 10Bossu P, Ciaramella A, Maria LM, et al. Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease[J]. Neurol Neurosurg Psychiatry, 2007, 78(8): 807-811.

共引文献33

同被引文献10

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部